financetom
Business
financetom
/
Business
/
Angi Q3 revenue misses expectations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Angi Q3 revenue misses expectations
Nov 4, 2025 1:39 PM

Overview

* Angi ( ANGI ) Q3 revenue fell 10% yr/yr, missing analyst expectations

* Operating income for Q3 grew 179% yr/yr, driven by lower expenses

* Adjusted EBITDA for Q3 beats analyst estimates, reflecting improved profitability

Outlook

* Company did not provide specific guidance for future quarters in its press release

Result Drivers

* PROPRIETARY GROWTH - Proprietary Service Requests and Leads increased due to improved customer experience and strong SEM performance

* OPERATING INCOME INCREASE - Operating income rose due to decreased depreciation and stock-based compensation expenses

* ADJUSTED EBITDA GROWTH - Adjusted EBITDA increased due to lower pro acquisition expenses and reduced fixed costs

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Miss $265.6 $268.94

Revenue mln mln (9

Analysts

)

Q3 EPS $0.23

Q3 Net $10.6

Income mln

Q3 Beat $39.7 $36.19

Adjusted mln mln (9

EBITDA Analysts

)

Q3 $21.8

Operatin mln

g Income

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the online services peer group is "buy."

* Wall Street's median 12-month price target for Angi Inc ( ANGI ) is $22.00, about 40.7% above its November 3 closing price of $13.05

* The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 15 three months ago

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Santander books record Q3 profit as strong US unit offsets weaker Brazil
Santander books record Q3 profit as strong US unit offsets weaker Brazil
Oct 29, 2025
By Jesús Aguado MADRID (Reuters) -Spain's Santander bank reported a 7.8% year-on-year rise in its third-quarter net profit, saying a strong performance in its U.S. business offset lower lending income and some weakness in Brazil. The net profit of 3.5 billion euros ($4.08 billion) in the July-September quarter reported by the euro zone's biggest bank came above the 3.39 billion...
New Gold Q3 Adjusted Net Income, Revenue Increase
New Gold Q3 Adjusted Net Income, Revenue Increase
Oct 29, 2025
03:49 AM EDT, 10/29/2025 (MT Newswires) -- New Gold ( NGD ) reported Q3 adjusted net income late Tuesday of $0.25 per diluted share, up from $0.08 a year earlier. Analysts polled by FactSet expected $0.18. Revenue for the quarter was $462.5 million, up from $252 million a year earlier. Three analysts surveyed by FactSet expected $419.8 million. Shares of...
NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares
NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares
Oct 29, 2025
ZURICH and NESS ZIONA, Israel, Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NLS or the Company) and Kadimastem Ltd. (TASE: KDST) (Kadimastem ( KMSTF )) today announced that, following the receipt of Nasdaq's approval for the listing of the Company's common shares and the trading of the Company on the Nasdaq Capital Market after completion of the merger between the Company, NLS...
Archrock Q3 Adjusted Earnings, Revenue Rise
Archrock Q3 Adjusted Earnings, Revenue Rise
Oct 29, 2025
03:55 AM EDT, 10/29/2025 (MT Newswires) -- Archrock ( AROC ) reported Q3 adjusted earnings late Tuesday of $0.42 per diluted share, up from $0.28 a year earlier. Three analysts polled by FactSet expected $0.42. Revenue for the quarter ended Sept. 30 was $382.4 million, up from $292.2 million a year earlier. Analysts surveyed by FactSet expected $378.2 million. ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved